Comparison of Tc-99m DTPA and Tc-99m MAG3 Perfusion Time-Activity Curves in Patients With Renal Allograft Dysfunction

The perfusion time-activity curve on DTPA renal scintigraphy shows a peak and plateau pattern which is usually absent or less marked when using tubular agents such as MAG3. The exact mechanism that results in this difference between the two tracers is not well understood. A descending pattern on MAG...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation proceedings 2006-03, Vol.38 (2), p.449-453
Hauptverfasser: Aktaş, A., Aras, M., Çolak, T., Gençoğlu, A., Karakayalı, H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 453
container_issue 2
container_start_page 449
container_title Transplantation proceedings
container_volume 38
creator Aktaş, A.
Aras, M.
Çolak, T.
Gençoğlu, A.
Karakayalı, H.
description The perfusion time-activity curve on DTPA renal scintigraphy shows a peak and plateau pattern which is usually absent or less marked when using tubular agents such as MAG3. The exact mechanism that results in this difference between the two tracers is not well understood. A descending pattern on MAG3 has been proposed to be due to decreased extraction. In this study we compared the diagnostic utility of perfusion patterns obtained with DTPA and MAG3 among patients with renal allograft dysfunction. This study included 48 patients with renal allograft dysfunction and 18 recipients with normal graft function. Every recipient had renal scintigraphy with Tc-99m MAG3 and Tc-99m DTPA 1 day apart. The second phase of the perfusion curve after the initial rise was classified as ascending, flat, or descending. In patients with a descending curve on DTPA study, we calculated the ratio of counts at peak perfusion to that at plateau (P:PL). Impaired perfusion was based on a deterioration of the peak-to-plateau pattern on DTPA and the presence of a flat-descending curve on MAG3. In patients with dysfunction, impaired perfusion was observed in 77% of DTPA and in 54% of MAG3 studies. A flat-descending curve on MAG3 was present in 44% of patients with normal graft function. By MAG3, 67% of acute rejection and 28% of chronic allograft nephropathy (CAN) cases showed deteriorated perfusion. The corresponding values for DTPA were 67% and 94%, respectively. A flat-ascending pattern on DTPA was more frequent in CAN than it was in acute rejection (33% and 17%, respectively). The sensitivity of DTPA perfusion pattern for diagnosing dysfunction was significantly greater than that for MAG3. Our results suggest that the major determinant of a curve pattern on DTPA or MAG3 study is the extraction relative to perfusion. Thus for patients with CAN, extraction is higher relative to perfusion, resulting in a lower P:PL ratio or an ascending curve on DTPA. Although the extraction of DTPA is less than that of MAG3, this level of extraction renders DTPA more sensitive to serial changes in renal function and pathophysiological mechanisms related to kidney function.
doi_str_mv 10.1016/j.transproceed.2006.01.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67769980</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041134506000078</els_id><sourcerecordid>67769980</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-8144f294d52f34e5da07c1321acde5d1693633654647d04d9f18eb24d136c4723</originalsourceid><addsrcrecordid>eNqNkE1vEzEQhi0EoqHwF5CFRG-79dd6d7mtEiiVihpVQRwt1x_gaNcOtjdS_j2OEqDHnkYjPzN-5wHgA0Y1Rphfb-scpU-7GJQxuiYI8RrhupQXYIG7llaEE_oSLBBiuMKUNRfgTUpbVHrC6GtwgXnDeszYAszLMO1kdCl4GCzcqKrvJ7jarAcovf7bfxtuKFybaOfkCrhxk6kGld3e5QNcznFvEnQermV2xucEf7j8Cz4YL0c4jGP4GaXNcHVIdvZlKvi34JWVYzLvzvUSfP_yebP8Wt3d39wuh7tKMdTlqisRLemZboilzDRaolZhSrBUunSY95RTWm7hrNWI6d7izjwSpjHlirWEXoKr097i6vdsUhaTS8qMo_QmzEnwtuV936ECfjqBKoaUorFiF90k40FgJI7SxVY8lS6O0gXCopQy_P78y_w4lbd_o2fLBfh4BmRScrRlkXLpP1dCNB0_plidOFOc7J2JIqkiVBntolFZ6OCek-cPzFGlOg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67769980</pqid></control><display><type>article</type><title>Comparison of Tc-99m DTPA and Tc-99m MAG3 Perfusion Time-Activity Curves in Patients With Renal Allograft Dysfunction</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Aktaş, A. ; Aras, M. ; Çolak, T. ; Gençoğlu, A. ; Karakayalı, H.</creator><creatorcontrib>Aktaş, A. ; Aras, M. ; Çolak, T. ; Gençoğlu, A. ; Karakayalı, H.</creatorcontrib><description>The perfusion time-activity curve on DTPA renal scintigraphy shows a peak and plateau pattern which is usually absent or less marked when using tubular agents such as MAG3. The exact mechanism that results in this difference between the two tracers is not well understood. A descending pattern on MAG3 has been proposed to be due to decreased extraction. In this study we compared the diagnostic utility of perfusion patterns obtained with DTPA and MAG3 among patients with renal allograft dysfunction. This study included 48 patients with renal allograft dysfunction and 18 recipients with normal graft function. Every recipient had renal scintigraphy with Tc-99m MAG3 and Tc-99m DTPA 1 day apart. The second phase of the perfusion curve after the initial rise was classified as ascending, flat, or descending. In patients with a descending curve on DTPA study, we calculated the ratio of counts at peak perfusion to that at plateau (P:PL). Impaired perfusion was based on a deterioration of the peak-to-plateau pattern on DTPA and the presence of a flat-descending curve on MAG3. In patients with dysfunction, impaired perfusion was observed in 77% of DTPA and in 54% of MAG3 studies. A flat-descending curve on MAG3 was present in 44% of patients with normal graft function. By MAG3, 67% of acute rejection and 28% of chronic allograft nephropathy (CAN) cases showed deteriorated perfusion. The corresponding values for DTPA were 67% and 94%, respectively. A flat-ascending pattern on DTPA was more frequent in CAN than it was in acute rejection (33% and 17%, respectively). The sensitivity of DTPA perfusion pattern for diagnosing dysfunction was significantly greater than that for MAG3. Our results suggest that the major determinant of a curve pattern on DTPA or MAG3 study is the extraction relative to perfusion. Thus for patients with CAN, extraction is higher relative to perfusion, resulting in a lower P:PL ratio or an ascending curve on DTPA. Although the extraction of DTPA is less than that of MAG3, this level of extraction renders DTPA more sensitive to serial changes in renal function and pathophysiological mechanisms related to kidney function.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2006.01.006</identifier><identifier>PMID: 16549144</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Acute Disease ; Biological and medical sciences ; Chronic Disease ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Graft Rejection - diagnostic imaging ; Graft Survival - physiology ; Humans ; Kidney - diagnostic imaging ; Kidney Transplantation - adverse effects ; Kidney Transplantation - physiology ; Kidney Tubules - diagnostic imaging ; Kidney Tubules - pathology ; Medical sciences ; Necrosis ; Postoperative Complications - diagnostic imaging ; Radionuclide Imaging ; Radiopharmaceuticals - pharmacokinetics ; Reproducibility of Results ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Technetium Tc 99m Mertiatide - pharmacokinetics ; Technetium Tc 99m Pentetate - pharmacokinetics ; Tissue, organ and graft immunology ; Transplantation, Homologous</subject><ispartof>Transplantation proceedings, 2006-03, Vol.38 (2), p.449-453</ispartof><rights>2006 Elsevier Inc.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-8144f294d52f34e5da07c1321acde5d1693633654647d04d9f18eb24d136c4723</citedby><cites>FETCH-LOGICAL-c408t-8144f294d52f34e5da07c1321acde5d1693633654647d04d9f18eb24d136c4723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0041134506000078$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,23909,23910,25118,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17695860$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16549144$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aktaş, A.</creatorcontrib><creatorcontrib>Aras, M.</creatorcontrib><creatorcontrib>Çolak, T.</creatorcontrib><creatorcontrib>Gençoğlu, A.</creatorcontrib><creatorcontrib>Karakayalı, H.</creatorcontrib><title>Comparison of Tc-99m DTPA and Tc-99m MAG3 Perfusion Time-Activity Curves in Patients With Renal Allograft Dysfunction</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>The perfusion time-activity curve on DTPA renal scintigraphy shows a peak and plateau pattern which is usually absent or less marked when using tubular agents such as MAG3. The exact mechanism that results in this difference between the two tracers is not well understood. A descending pattern on MAG3 has been proposed to be due to decreased extraction. In this study we compared the diagnostic utility of perfusion patterns obtained with DTPA and MAG3 among patients with renal allograft dysfunction. This study included 48 patients with renal allograft dysfunction and 18 recipients with normal graft function. Every recipient had renal scintigraphy with Tc-99m MAG3 and Tc-99m DTPA 1 day apart. The second phase of the perfusion curve after the initial rise was classified as ascending, flat, or descending. In patients with a descending curve on DTPA study, we calculated the ratio of counts at peak perfusion to that at plateau (P:PL). Impaired perfusion was based on a deterioration of the peak-to-plateau pattern on DTPA and the presence of a flat-descending curve on MAG3. In patients with dysfunction, impaired perfusion was observed in 77% of DTPA and in 54% of MAG3 studies. A flat-descending curve on MAG3 was present in 44% of patients with normal graft function. By MAG3, 67% of acute rejection and 28% of chronic allograft nephropathy (CAN) cases showed deteriorated perfusion. The corresponding values for DTPA were 67% and 94%, respectively. A flat-ascending pattern on DTPA was more frequent in CAN than it was in acute rejection (33% and 17%, respectively). The sensitivity of DTPA perfusion pattern for diagnosing dysfunction was significantly greater than that for MAG3. Our results suggest that the major determinant of a curve pattern on DTPA or MAG3 study is the extraction relative to perfusion. Thus for patients with CAN, extraction is higher relative to perfusion, resulting in a lower P:PL ratio or an ascending curve on DTPA. Although the extraction of DTPA is less than that of MAG3, this level of extraction renders DTPA more sensitive to serial changes in renal function and pathophysiological mechanisms related to kidney function.</description><subject>Acute Disease</subject><subject>Biological and medical sciences</subject><subject>Chronic Disease</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Graft Rejection - diagnostic imaging</subject><subject>Graft Survival - physiology</subject><subject>Humans</subject><subject>Kidney - diagnostic imaging</subject><subject>Kidney Transplantation - adverse effects</subject><subject>Kidney Transplantation - physiology</subject><subject>Kidney Tubules - diagnostic imaging</subject><subject>Kidney Tubules - pathology</subject><subject>Medical sciences</subject><subject>Necrosis</subject><subject>Postoperative Complications - diagnostic imaging</subject><subject>Radionuclide Imaging</subject><subject>Radiopharmaceuticals - pharmacokinetics</subject><subject>Reproducibility of Results</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Technetium Tc 99m Mertiatide - pharmacokinetics</subject><subject>Technetium Tc 99m Pentetate - pharmacokinetics</subject><subject>Tissue, organ and graft immunology</subject><subject>Transplantation, Homologous</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE1vEzEQhi0EoqHwF5CFRG-79dd6d7mtEiiVihpVQRwt1x_gaNcOtjdS_j2OEqDHnkYjPzN-5wHgA0Y1Rphfb-scpU-7GJQxuiYI8RrhupQXYIG7llaEE_oSLBBiuMKUNRfgTUpbVHrC6GtwgXnDeszYAszLMO1kdCl4GCzcqKrvJ7jarAcovf7bfxtuKFybaOfkCrhxk6kGld3e5QNcznFvEnQermV2xucEf7j8Cz4YL0c4jGP4GaXNcHVIdvZlKvi34JWVYzLvzvUSfP_yebP8Wt3d39wuh7tKMdTlqisRLemZboilzDRaolZhSrBUunSY95RTWm7hrNWI6d7izjwSpjHlirWEXoKr097i6vdsUhaTS8qMo_QmzEnwtuV936ECfjqBKoaUorFiF90k40FgJI7SxVY8lS6O0gXCopQy_P78y_w4lbd_o2fLBfh4BmRScrRlkXLpP1dCNB0_plidOFOc7J2JIqkiVBntolFZ6OCek-cPzFGlOg</recordid><startdate>20060301</startdate><enddate>20060301</enddate><creator>Aktaş, A.</creator><creator>Aras, M.</creator><creator>Çolak, T.</creator><creator>Gençoğlu, A.</creator><creator>Karakayalı, H.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060301</creationdate><title>Comparison of Tc-99m DTPA and Tc-99m MAG3 Perfusion Time-Activity Curves in Patients With Renal Allograft Dysfunction</title><author>Aktaş, A. ; Aras, M. ; Çolak, T. ; Gençoğlu, A. ; Karakayalı, H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-8144f294d52f34e5da07c1321acde5d1693633654647d04d9f18eb24d136c4723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Acute Disease</topic><topic>Biological and medical sciences</topic><topic>Chronic Disease</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Graft Rejection - diagnostic imaging</topic><topic>Graft Survival - physiology</topic><topic>Humans</topic><topic>Kidney - diagnostic imaging</topic><topic>Kidney Transplantation - adverse effects</topic><topic>Kidney Transplantation - physiology</topic><topic>Kidney Tubules - diagnostic imaging</topic><topic>Kidney Tubules - pathology</topic><topic>Medical sciences</topic><topic>Necrosis</topic><topic>Postoperative Complications - diagnostic imaging</topic><topic>Radionuclide Imaging</topic><topic>Radiopharmaceuticals - pharmacokinetics</topic><topic>Reproducibility of Results</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Technetium Tc 99m Mertiatide - pharmacokinetics</topic><topic>Technetium Tc 99m Pentetate - pharmacokinetics</topic><topic>Tissue, organ and graft immunology</topic><topic>Transplantation, Homologous</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aktaş, A.</creatorcontrib><creatorcontrib>Aras, M.</creatorcontrib><creatorcontrib>Çolak, T.</creatorcontrib><creatorcontrib>Gençoğlu, A.</creatorcontrib><creatorcontrib>Karakayalı, H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aktaş, A.</au><au>Aras, M.</au><au>Çolak, T.</au><au>Gençoğlu, A.</au><au>Karakayalı, H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of Tc-99m DTPA and Tc-99m MAG3 Perfusion Time-Activity Curves in Patients With Renal Allograft Dysfunction</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2006-03-01</date><risdate>2006</risdate><volume>38</volume><issue>2</issue><spage>449</spage><epage>453</epage><pages>449-453</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><abstract>The perfusion time-activity curve on DTPA renal scintigraphy shows a peak and plateau pattern which is usually absent or less marked when using tubular agents such as MAG3. The exact mechanism that results in this difference between the two tracers is not well understood. A descending pattern on MAG3 has been proposed to be due to decreased extraction. In this study we compared the diagnostic utility of perfusion patterns obtained with DTPA and MAG3 among patients with renal allograft dysfunction. This study included 48 patients with renal allograft dysfunction and 18 recipients with normal graft function. Every recipient had renal scintigraphy with Tc-99m MAG3 and Tc-99m DTPA 1 day apart. The second phase of the perfusion curve after the initial rise was classified as ascending, flat, or descending. In patients with a descending curve on DTPA study, we calculated the ratio of counts at peak perfusion to that at plateau (P:PL). Impaired perfusion was based on a deterioration of the peak-to-plateau pattern on DTPA and the presence of a flat-descending curve on MAG3. In patients with dysfunction, impaired perfusion was observed in 77% of DTPA and in 54% of MAG3 studies. A flat-descending curve on MAG3 was present in 44% of patients with normal graft function. By MAG3, 67% of acute rejection and 28% of chronic allograft nephropathy (CAN) cases showed deteriorated perfusion. The corresponding values for DTPA were 67% and 94%, respectively. A flat-ascending pattern on DTPA was more frequent in CAN than it was in acute rejection (33% and 17%, respectively). The sensitivity of DTPA perfusion pattern for diagnosing dysfunction was significantly greater than that for MAG3. Our results suggest that the major determinant of a curve pattern on DTPA or MAG3 study is the extraction relative to perfusion. Thus for patients with CAN, extraction is higher relative to perfusion, resulting in a lower P:PL ratio or an ascending curve on DTPA. Although the extraction of DTPA is less than that of MAG3, this level of extraction renders DTPA more sensitive to serial changes in renal function and pathophysiological mechanisms related to kidney function.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>16549144</pmid><doi>10.1016/j.transproceed.2006.01.006</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1345
ispartof Transplantation proceedings, 2006-03, Vol.38 (2), p.449-453
issn 0041-1345
1873-2623
language eng
recordid cdi_proquest_miscellaneous_67769980
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Acute Disease
Biological and medical sciences
Chronic Disease
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Graft Rejection - diagnostic imaging
Graft Survival - physiology
Humans
Kidney - diagnostic imaging
Kidney Transplantation - adverse effects
Kidney Transplantation - physiology
Kidney Tubules - diagnostic imaging
Kidney Tubules - pathology
Medical sciences
Necrosis
Postoperative Complications - diagnostic imaging
Radionuclide Imaging
Radiopharmaceuticals - pharmacokinetics
Reproducibility of Results
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Technetium Tc 99m Mertiatide - pharmacokinetics
Technetium Tc 99m Pentetate - pharmacokinetics
Tissue, organ and graft immunology
Transplantation, Homologous
title Comparison of Tc-99m DTPA and Tc-99m MAG3 Perfusion Time-Activity Curves in Patients With Renal Allograft Dysfunction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T03%3A39%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20Tc-99m%20DTPA%20and%20Tc-99m%20MAG3%20Perfusion%20Time-Activity%20Curves%20in%20Patients%20With%20Renal%20Allograft%20Dysfunction&rft.jtitle=Transplantation%20proceedings&rft.au=Akta%C5%9F,%20A.&rft.date=2006-03-01&rft.volume=38&rft.issue=2&rft.spage=449&rft.epage=453&rft.pages=449-453&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/j.transproceed.2006.01.006&rft_dat=%3Cproquest_cross%3E67769980%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67769980&rft_id=info:pmid/16549144&rft_els_id=S0041134506000078&rfr_iscdi=true